DirectorsTalk

Stephen Sanderson CEO of UK Oil and Gas talks about their £336bn Oil Discovery in Weald Basin, Surry UK. For more news and interviews visit: http://www.directorstalk.com http://www.directorstalkinterviews.com #oil #uk # #gas

Ian Strafford-Taylor CEO of FairFX plc discusses exclusively the reasoning behind their new TV advertising campaign with #SKY Sports #F1 and any further advertising plans. #FAIRFX Plc is based in the City of London and provides you with the best value Travel Money around. They offer a great service using state of the art technology and by cutting out the middle man. To buy your Travel Money, you simply buy online (using any Debit Card or Credit Card or by internet bank transfer) and then tell us how you want to get your currency. Mr. Strafford-Taylor is one of the Founders and has been a Director since 2007. Mr Strafford- Taylor has held a number of senior banking roles, including Business Unit Controller and Head of International Securities Lending at Morgan Stanley, where he worked from 1985 to 1992. Following this, Mr. Strafford-Taylor moved to UBS where he worked for 13 years as Managing Director and Global Head of Securities Borrowing & Lending, Fixed Income Repo and Prime Brokerage. Mr. Strafford-Taylor is a chartered accountant, qualifying with Arthur Andersen in 1985. For more #stock #shares and #investing #news and #interviews visit: http://www.directorstalk.com

Marcus Leaver CEO of The Quarto Group, Inc discusses his thoughts on Quarto's outlook, division performance and expectations for 2015. The Quarto Group (LSE: QRT) is the leading global illustrated book publisher and distribution group and is listed on the #London #Stock #Exchange. Marcus Leaver has been Chief Executive Officer since December 2012 having joined the board of Quarto as Chief Operating Officer in May 2012. Prior to #Quarto, he worked in the USA from 2005, latterly as President of Sterling Publishing, a subsidiary of Barnes & Noble, the leading bricks-and-mortar bookseller in the US. Before living and working in the US, he worked in London for Chrysalis Group plc, a London Stock Exchange-listed media company, latterly as CEO of Chrysalis Books Group, from 2002, and prior to that Corporate Development Director and in a number of different general management roles, from 1998. Marcus graduated from the University of East Anglia with a degree in Art History, and received his MBA from London Business School. Marcus is a member of the Nominations Committee. For more #investing #news and #interviews visit: http://www.directorstalk.com

Stewart White CEO of #Collagen Solutions provides a trading update. "...expect a valuation 100 million pounds by 2020" Collagen Solutions Plc is a global provider of medical grade collagen formulations and components for use in regenerative medicine, medical devices and in-vitro diagnostics. Dr Stewart White was CEO of Collbio and has recent and direct board experience of an AIM quoted company. Stewart has international experience in operations, business and product development, and 'Good Manufacturing Practices' (GMP) compliant manufacturing of collagen medical devices, advanced biologics and Active Pharmaceutical Ingredients in both Small to Medium Enterprises as well as global pharmaceutical companies. Stewart is a graduate of the University of Strathclyde and holds a First Class degree in Applied #Microbiology, a Ph.D. in Fermentation #Technology and Bioprocessing and an MBA. For more #investing news and #interviews visit: www.directorstalk.com

Tony Richardson, Chief Executive Officer of Venn Life Sciences explains their leading edge in the industry and looking forward through 2015 looking to expand further in central and eastern Europe. Venn Life Scienes are a European CRO with over 24 years’ experience in the management & resourcing of clinical trials. Therapeutically focused, they have worked with pharmaceutical, biotech and medical device companies for a quarter of a century, navigating efficiently the often difficult European clinical trial landscape. Their close relationships with hospitals, investigators, regulators and key opinion leaders coupled with expertise as a team make planning and running trials easier for all. Tony Richardson is CEO of Venn Life Sciences. He has over 15 years experience in the Life Science arena. Mr. Richardson has held key leadership positions in a number of Medical Technology companies and has accumulated considerable transaction experience including IPO, financings and M&A. #venn #science #trading #business #lse #stocks #shares